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Thyroid cancer is the most common endocrine malignancy. Anaplastic thyroid cancer is one of the 
most aggressive thyroid tumors. It is known that activation of oncogenes and/or inactivation of 
tumor suppressor genes in tumor cells promotes tumorigenesis. The microenvironment of the tumor 
also plays a key role on cancer development and progression in a variety of tumors. However, the 
mechanisms by which tumor-stroma crosstalk in thyroid cancer remains poorly characterized. In this 
study we aimed to understand how interactions between fibroblasts and anaplastic thyroid cancer 
cells contribute to thyroid carcinogenesis. We first characterized the phenotypic changes of human 
fibroblasts in vitro through co-cultures by using transwells as well as by using anaplastic thyroid cancer 
cells-derived conditioned media. We found that fibroblasts acquired an activated phenotype or also 
known as cancer-associated fibroblast phenotype after being in contact with soluble factors secreted 
from anaplastic thyroid cancer cells, compared to the fibroblasts in mono-cultures. All the changes were 
partly mediated through Src/Akt activation. Treatment with the antioxidant N-acetyl-cysteine reversed 
in part the metabolic phenotype of activated fibroblasts. Remarkably, conditioned media obtained 
from these activated fibroblasts promoted cell proliferation and invasion of follicular thyroid cancer 
cell line, FTC-133 cells. Thus, a reciprocal and dynamic interaction exists between tumor and stromal 
cells, which results in the promotion of thyroid tumorigenesis. The present studies have advanced the 
understanding of the molecular basis of tumor-stroma communications, enabling identification and 
targeting of tumor-supportive mechanisms for novel treatment modalities.
Thyroid cancer (TC) is the most common form of endocrine malignancy and their incidence has been increasing 
rapidly in the past three decades worldwide, mainly in women1,2. About 40,000 cases of female TC are expected 
to be diagnosed in 2018 in the United States2. Among the different types of TC, anaplastic thyroid cancer (ATC) 
is a rare type of cancer but it is one of the most aggressive and chemotherapy-resistant types of all thyroid car-
cinomas. Characterized by its undifferentiated cells, it spreads quickly to distant organs, mainly lung and bone, 
and does not respond well to standardized therapy3,4. Currently, no effective target treatments are available that 
can improve overall survival4,5. Therefore, there is a critical need to identify new biological targets that can be 
translated into therapeutic approaches.
The effects of oncogenic transformation of epithelial tumor cells on cancer progression have been well estab-
lished. More recent evidences, however, have shown that tumor microenvironment (TME) also influences cancer 
cell behavior and disease progression in many different types of neoplasia6. This TME is an active and dynamic 
component supporting tumor growth, helping the tumor epithelial cell in its survival. The TME comprises, in 
addition to extracellular matrix, the epithelial cells (tumor cells) and a variety of non-epithelial cells (or stromal 
cells), being activated fibroblasts one of their main cell components7.
Fibroblasts are quiescent in normal conditions. To acquire tumor-supporting phenotypes, normal fibro-
blasts undergo activation through different mechanisms. Numerous studies have demonstrated that oncogenic 
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paracrine signaling produced by epithelial tumor cells, including growth factors, chemokines and exosomes 
among others, may recruit fibroblasts to the tumor site and activate quiescent fibroblasts8–12. Once activated, 
fibroblasts [also named myofibroblasts or cancer-associated fibroblasts (CAFs)] become metabolically active, pro-
liferate and secrete soluble factors influencing cancer cell behavior and playing key roles in the process of cancer 
development and progression in a variety of tumors7,8,13.
Despite the availability of numerous reports describing the essential contribution of activated fibro-
blasts or CAFs on carcinogenesis in many different types of cancer, a detailed understanding of the biology of 
tumor-stroma crosstalk in thyroid cancer is largely under investigated. Therefore, in order to improve our knowl-
edge of the basis of reciprocal cell-cell interactions in ATC and their influence on tumor progression, in our study 
we established in vitro mono and co-cultures of human fibroblasts and human ATC cells, 8505c and KTC-2. We 
first investigated the effects of the ATC cells secreted factors on fibroblasts phenotype, to recapitulate the tumor 
cell secretome effects exerted in the immediate proximity of stromal cells. We also explored the impact of parac-
rine signals released from fibroblasts after treatment with ATC cells-derived conditioned media (CM), on thyroid 
tumorigenesis. We found that factors secreted from tumor cells may reprogram the metabolism, phenotype and 
secretome of fibroblasts acquiring activation features. In parallel, these activated fibroblasts secrete soluble factors 
to modulate tumor epithelial cell phenotype, including cell proliferation and invasion of FTC-133 cells, potentiat-
ing thyroid cancer progression. Based on these observations, our results suggest the presence of a paracrine loop 
between tumor cells and stromal fibroblasts in TC which ends in the promotion of TC aggressiveness.
Results
Metabolic and phenotypic reprogramming of human fibroblasts induced by interactions 
between tumor and stromal cells in co-cultures. It is well known that the crosstalk between cancer 
and stromal cells has an essential influence on cancer initiation, development and progression in many tumor 
types6,14,15. However, a detailed comprehension of the basis of these interactions on thyroid tumor progression has 
not yet been extensively investigated. In order to better understand this interplay in ATC, we first characterized 
phenotypic changes due to tumor-stromal cells interactions, by co-culturing of human fibroblasts, a key compo-
nent of the tumor stroma, with ATC cells, in transwell chambers (Fig. 1A). Two different ATC cells, 8505c and 
KTC-2, were co-cultured with normal lung fibroblasts (MRC-5 cells) for 24 h or 48 h and a variety of parameters 
were evaluated.
Studies have shown that reactive oxygen species (ROS) can induce the activation of multiple signaling cas-
cades that mediate the oncogenic phenotype8,16,17. Figures 1B–E show ROS production in co-cultures of ATC 
and MRC-5 cells. It has been reported that tumor epithelial cells produce high levels of ROS16,17. As expected, 
we found that mono-cultures of 8505c cells showed a significant higher basal ROS production compared to nor-
mal fibroblasts [(Fig. 1B and 1C (quantitative analysis)]. Notably, after 2 days of co-culture with 8505c cells, we 
observed that MRC-5 cells [labeled as MRC-5 (+8505c)] show a significant increase in ROS production (shown 
by the shift to the right in Fig. 1D and quantification in Fig. 1E). In contrast, human ATC cells did not show dif-
ferences in ROS production, under the same culture times and conditions (data not shown).
It has previously been reported that ROS production drives the onset of inflammation in the TME16. Besides, 
previous studies describe that one of the main mechanism of communication between fibroblast and tumor 
cell is mediated by pro-inflammatory cytokines8. We decided to focus our attention on interleukin-6 (IL-6), 
an acknowledged marker of inflammation and one of the major cytokine in the TME18. Furthermore, several 
reports indicate that this cytokine contributes to tumor progression. We analyzed changes in this inflammatory 
marker, in co-cultures. Figure 1F shows that 8505c cells expressed higher levels of IL-6 mRNA than MRC-5 cells. 
Importantly, co-culturing for 24 h with 8505c cells, the expression of IL-6 mRNA in MRC-5 cells was signifi-
cantly increased by ~10-fold (Fig. 1G). We further determined the secreted IL-6 in the media by enzyme-linked 
immunosorbent assay (ELISA). IL-6 was previously detected in culture medium of KTC-2 cells19. In agreement 
with those observations, the secreted IL-6 was slightly higher in mono-cultures of KTC cells than MRC-5 cells 
(Fig. 1H). Most importantly, co-culturing with 8505c [MRC-5 (+8505c)] or KTC-2 cells [MRC-5 (+KTC-2)] for 
48 h, the IL-6 secreted by MRC-5 was significantly elevated (Fig. 1I).
Besides inflammation, oxidative stress can activate the hypoxia inducible transcription factor-1α (HIF-1α) in 
the tumor stroma20. We therefore measured the expression levels of this critical transcription factor. High expres-
sion levels of HIF-1α have been found in dedifferentiated ATC21,22. Consistently, RT-PCR analysis showed signif-
icant higher levels in the transcript of HIF-1α in the two ATC cell lines used, than in normal fibroblasts (Fig. 1J). 
More interestingly, MRC-5 cells increased the expression levels of this transcription factor during co-culturing 
with 8505c cells (Fig. 1K). Previous reports have shown that HIF-1α induces the expression of glucose transporters 
and glycolytic enzymes20,22,23. Among different subtypes of glucose transporters, glucose transporter 1 (GLUT-1) 
plays a critical role in tumor progression22 and that overexpression of GLUT-1 was reported in thyroid cancer24. 
Consistently, we found that the expression of GLUT-1 in MRC-5 cells during co-culturing with ATC cells was 
increased at the mRNA levels (Fig. 1L) as well as at the protein levels (Fig. 1M). In agreement with the changes 
in the levels of GLUT-1, during co-culturing with 8505c cells, the mRNA levels of one of the better characterized 
glycolytic enzyme, lactate dehydrogenase A (LDH-A)23, were also significantly increased by ~2.5-fold in MRC-5 
cells [Fig. 1N (mono-cultures) and 1O (co-cultures)].
Numerous reports showed that ROS as well as IL-6 induce the activation of fibroblasts8,16,17. To test the pos-
sibility that MRC-5 could be activated when co-culturing with ATC, we analyzed the expression levels of two 
well-known markers of cancer-associated fibroblasts (CAF) phenotype or activated fibroblasts: platelet-derived 
growth factor receptor–β (PDGFR-β) and α-smooth muscle actin (α-SMA)7,13. We found a significantly increased 
protein levels of PDGFR-β by ~3-fold after co-culturing with 8505c cells for 24 h [(Fig. 1P, compare lanes 1 and 
2 (mono-cultures) with lanes 3–5 (co-cultures), and quantitative analysis, Fig. 1R)]. A similar increase was also 
detected for α-SMA by ~4-fold after co-culturing with 8505c cells for 24 h [(Fig. 1Q, compare lanes 1 and 2 
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Figure 1. Co-cultures of ATC cells with fibroblasts modify the MRC-5 cells phenotype. (A) Schematic 
representation of co-cultures by using transwells. Total intracellular levels of ROS in MRC-5 and 8505c cells. 
(B–E) Basal ROS production in mono-cultures of MRC-5 and 8505c cells: representative histogram (B), and 
quantification (C). ROS production in MRC-5 after 48 h of co-cultures with 8505c: representative histogram 
(D), and quantification (E). Data are expressed as mean ± SD of 4 independent experiments (n = 4) with 
triplicate samples for each experimental group. Expression levels of IL-6 (F,G). mRNA levels by RT-qPCR 
in MRC-5 and 8505c mono-cultures (F); mRNA in MRC-5 cells after co-culture with 8505c cells for 24 h 
(G). Data are expressed as mean ± SD of 3 independent experiments (n = 3) with triplicate samples for each 
experimental group. Secreted protein in mono-cultures of fibroblasts and ATC cells by ELISA (H); secreted 
protein in MRC-5 cells after co-culture with ATC cells for 48 h (I). Data are expressed as mean ± SD of 4 
independent experiments (n = 4) with triplicate samples for each experimental group. Expression levels of 
HIF-1A (J,K). mRNA levels by RT-PCR in MRC-5 and ATC cells mono-cultures (J) and in MRC-5 cells after 
co-cultures with 8505c cells (K). Data are expressed as mean ± SD of 3 independent experiments (n = 3) with 
triplicate samples for each experimental group. GLUT-1 expression in MRC-5 cells after co-culture with ATC 
cells (L,M). mRNA by RT-PCR in MRC-5 and MRC-5 cells co-cultured with 8505c and KTC-2 cells for 24 h 
(L). Data are expressed as mean ± SD of 3 independent experiments (n = 3) with triplicate samples for each 
experimental group. Immunoblot analysis in MRC-5 cells after 48 h of co-cultures (M). The figure shows a 
representative Western Blot of 3 independent experiments (n = 3) with duplicate samples for each experimental 
group. The same blot was stripped and re-blotted using anti-GAPDH antibody for loading control [(M); full 
blot is shown in the Supplemental Information, Full Original Blots-I]. Expression levels of LDH-A (N,O). 
mRNA RT-PCR in MRC-5 and 8505c mono-cultures (N) and in MRC-5 cells after co-cultures with 8505c cells 
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(mono-cultures) with lanes 3–5 (co-cultures), and quantitative analysis, Fig. 1R)]. Taken together, our results 
strongly indicate that tumor-stromal cells interactions modified fibroblasts phenotype by reprogramming their 
metabolism; their secretory functions and their distinctive expression patterns of proteins.
Induction of CAF-markers protein expression in MRC-5 by 8505c- and KTC-2 cells-derived con-
ditioned media (CM). Our findings by using transwell system (Fig. 1) led us to hypothesize that factors 
secreted by ATC cells could induce phenotypic changes in MRC-5 cells. To test if transformed thyroid epithelia 
may activate fibroblasts in a paracrine way, we first investigated the direct effect of factors secreted by ATC cells 
in the CM on the expression levels of known markers of fibroblast activation as PDGFR-β and α-SMA in MRC-5 
cells. In accordance with the transwell system, Western Blot analysis revealed increased abundance of PDGFR-β 
by ~3- and 1.5-fold in MRC-5 cells incubated for 24 h or 48 h respectively with CM derivate from 8505c cells 
compared with complete media [Fig. 2B, compare lanes 1 (24 h) and 6 (48 h) (controls, with 5% FBS) with lanes 
2 and 3 (24 h) and 7 and 8 (48 h)] and KTC-2-derived CM [Fig. 2B, compare lanes 1 (24 h) and 6 (48 h) (controls, 
with 5% FBS) with lanes 4 and 5 (24 h) and 9 and 10 (48 h)]. Figure 2C shows the quantitative comparison of 
the band intensities from Fig. 2B. That PDGFR-β protein levels were increased in MRC-5 cells prompted to us 
to ascertain whether ATC cells secreted platelet derived growth factors (PDGF) into the media. We found that 
8505c and KTC-2 cells secreted high amounts of PDGF (94.5 pg/mL and 26.1 pg/mL, respectively) into the media 
as compared with normal thyroid cells and MRC-5 cells. PDGF were not detectable in the media derived from 
normal thyroid cells and MRC-5 cells under the same experimental conditions (Fig. 2D). Thus PDGF could serve 
as a causative molecule to activate fibroblasts via the elevated PDGFR-β.
Further, we found that another activator marker, α-SMA, was also elevated in MRC-5 [~1.2-fold at 48 h under 
the same culture conditions; Fig. 2E compare lane 6 (control, with 5% FBS) with lanes 7 and 8 (8505c-derived 
CM) and 9 and 10 (KTC-2-derived CM); quantitative analysis shown in Fig. 2F]. Altogether, these results suggest 
that ATC cells-derived CM induced an activated phenotype in MRC-5 cells similar to that induced by co-cultures 
and that ATC cells-derived CM can be used to gain additional insights on the effects of ATC cells-secreted factors 
on MRC-5 cell phenotype.
ATC cells-derived CM stimulates cell proliferation of MRC-5 cells through the activation of Src 
and Akt pathways. Previous reports indicate that, in addition to the increased protein levels of markers of 
the CAF-phenotype, once activated, fibroblasts also increase their rate of proliferation7,8,13. We therefore exam-
ined cell proliferation of MRC-5 cells, first by counting cells after treatment with ATC cells-derived CM. As 
shown in Fig. 3A, MRC-5 cell number was significantly increased by treatment with 8505c-derived CM at 24 h 
and 48 h. Similar results were obtained by stimulation with KTC-2-derived CM (Fig. 3B).
We also examined the effects of ATC cells-derived CM on MRC-5 cells proliferation by 3-(4,5-dime
thylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. Consistent with the increases in the cell num-
ber, MRC-5 cell proliferation was significantly increased after treatment with 8505c- and KTC-2-derived CM at 
24 h and 48 h (Fig. S1, a and b).
The findings that ATC cells-derived CM modified cell proliferation of MRC-5 cells prompted us to evaluate 
the abundance of key regulators of cell cycle. In agreement with the stimulation of proliferation, Western Blot 
assays showed that the protein levels of cyclin-dependent kinase inhibitor, p21, was lower by ~1.5-fold in MRC-5 
cells incubated for 48 h with 8505c-derived CM [Fig. 3C, compare lane 6 (control with 5% FBS), with lanes 7 and 
8]. We also found a decrease in the protein levels of p21 by ~2.5-fold in MRC-5 cells when KTC-2 CM were used 
[Fig. 3C, compare lane 6 (control with 5% FBS), with lanes 9 and 10]. The band intensities were quantified and the 
extents of changes are shown in Fig. 3D.
We next determined another essential cell cycle regulator, p27. Figure 3E, shows that the p27 protein levels 
were also lower by ~1.4-fold in MRC-5 cells treated with 8505c-derived CM at both times analyzed [Fig. 3E, com-
pare lanes 1 (24 h) and 6 (48 h) (controls with 5% FBS) with lanes 2 and 3 (24 h) and 7 and 8 (48 h)]. Consistently, 
the abundance of p27 was decreased by ~1.8- and 2.4-fold in MRC-5 cells incubated with KTC-2-derived CM at 
24 h and 48 h respectively [Fig. 3E, compare lanes 1 (24 h) and 6 (48 h) (controls with 5% FBS) with lanes 4 and 
5 (24 h) and 9 and 10 (48 h)]. The intensities of the bands in Fig. 3E were determined, and the graph is shown in 
Fig. 3F. These results indicate that the effect/s of secreted factors from ATC cells on fibroblasts cell proliferation is 
mediated, at least in part, by modulation of the regulators of the G1-S cell cycle.
The Src family of protein tyrosine kinases is a key regulator of broad cellular functions, including cell pro-
liferation and cell growth through the activation of multiple signaling pathways. In addition, it has been 
reported the involvement of Src in the activation of fibroblasts25. To determine whether the decreased abun-
dance of p21/p27 together with the observed phenotypic changes in human fibroblasts were also accompanied 
by the over-activation of Src in MRC-5 cells incubated with ATC cells-derived CM, we analyzed the protein 
levels of phosphorylated Src (p-Src) and total Src (Fig. 3G). Consistently, we found a marked upregulation of 
for 24 h (O). Data are expressed as mean ± SD of 3 independent experiments (n = 3) with triplicate samples 
for each experimental group. Immunoblot analysis of PDGFR-β (P) and α-SMA (Q) in mono-cultures of 
MRC-5 cells or after co-cultures with 8505c for 24 h or 48 h. The figure shows representative Western Blots of 
3 independent experiments (n = 3) with duplicate (MRC-5 alone) or triplicate (MRC-5 + ATC cell) samples 
for each experimental group. The same blot was cut or stripped and blotted using anti-GAPDH antibody (Full 
blot is shown in the Supplemental Information, Full Original Blots-I). Quantification of relative expression 
of PDGFR-β and α-SMA proteins in human fibroblasts after using GAPDH as loading control (R). Data are 
expressed as mean ± SD. *p < 0.05, **p < 0.005, ***p < 0.0005 and ****p < 0.0001. ns, not significant.
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Src phosphorylated in MRC-5 cells incubated for 24 h with 8505c- and KTC-2-derived CM as compared with 
MRC-5 cells treated with DMEM-FBS 5% (controls), without major modifications in total Src [Fig. 3G, compare 
lane 1 (control) with lanes 2 and 3 (8505c-derived CM) and 4 to 5 (KTC-2-derived CM)]. The quantitative data 
of the band intensities are shown in Fig. 3H. These observations suggest that Src pathway is affected in fibroblasts 
after exposure to ATC cells-derived CM and that it could play a crucial role in cell proliferation as well as in the 
activation of MRC-5 cells.
It has been reported that Src regulates cell processes via activation of multiple downstream signaling pathways 
including phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt). Besides, many studies have shown that Akt is 
involved in the regulation of proliferation through alteration in changing of the expression of key regulators26. To 
determine whether the decreased abundance of p21/p27 was also accompanied by the over-activation of Akt in 
MRC-5 cells incubated with ATC cells-derived CM, we determined the protein levels of phosphorylated (p-Akt) 
and total Akt (Fig. 3I). The ratios of p-Akt to total Akt levels indicate that there was an ~1.8- and 1.4-fold increase 
in the ratios of p-Akt to total Akt in MRC-5 cells treated with 8505c-derived CM in a time-dependent manner 
[Fig. 3I, compare lanes 1 (24 h) and 6 (48 h) (controls with 5% FBS), with lanes 2 and 3 (24 h) and 7 and 8 (48 h)]. 
We obtained similar results for MRC-5 by using CM obtained from KTC-2 cells [Fig. 3I, compare lanes 1 (24 h) 
and 6 (48 h) (controls with 5% FBS) with lanes 4 and 5 (24 h) and 9 and 10 (48 h)]. The quantitative data of the 
band intensities are shown in Fig. 3J, indicating that in addition to accelerating the G1-S cell cycle progression, 
Figure 2. ATC cells-derived CM induced the protein expression of CAF-markers in human fibroblasts. (A) 
Schematic representation of CM preparation from ATC cells and treatment of MRC-5 cells. (B–F) Effects 
of CM from ATC cells on CAFs markers in MRC-5 cells. Immunoblot analysis of PDGFR-β in MRC-5 cells 
grown under normal conditions (control) or exposed to CM derived from ATC cells, 8505c and KTC-2, for 
24 h and 48 h (B). The figure shows a representative Western Blot of 3 independent experiments (n = 3) with 
duplicate samples for each experimental group. Quantification of relative expression of PDGFR-β protein in 
human fibroblasts after using GAPDH as loading control. The blot was cut and blotted using anti-GAPDH 
antibody. [(C) full blot is shown in the Supplemental Information, Full Original Blots-II]. Data are expressed as 
mean ± SD. (D) Concentrations of platelet derived growth factors in the CM of normal thyroid, MRC-5, 8505c 
and KTC-2 cells determined by ELISA as described in Methods and Materials. Data are expressed as mean ± SD 
of 2 independent experiments (n = 2) with triplicate samples for each experimental group; *Not detectable. (E) 
Immunoblot analysis of α-SMA in MRC-5 cells grown under normal conditions (control) or exposed to CM 
derived from ATC cells, 8505c and KTC-2, for 24 h and 48 h. The figure shows a representative Western Blot of 
3 independent experiments (n = 3) with duplicate samples for each experimental group. (F) Quantification of 
relative expression of α-SMA protein in human fibroblasts after using GAPDH as loading control. The blot was 
stripped and re-blotted using anti-GAPDH antibody (full blot is shown in the Supplemental Information, Full 
Original Blots-II). Data are expressed as mean ± SD. *p < 0.05 and **p < 0.005. ns, not significant.
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Figure 3. ATC cells-derived CM increased proliferation of MRC-5 cells. Proliferation of MRC-5 cells, 
incubated with 8505c-derived CM (A) or KTC-2-derived CM (B) for 24 h or 48 h, estimated by cell counting. 
Data are expressed as mean ± SD of 4 independent experiments (n = 4) with triplicate samples for each 
experimental group. Immunoblot analysis of p21 in MRC-5 cells grown under normal conditions (control) 
or exposed to CM derived from ATC cells, 8505c and KTC-2, for 24 h and 48 h (C). The figure shows a 
representative Western Blot of 3 independent experiments (n = 3) with duplicate samples for each experimental 
group. Quantification of relative expression of p21 protein in human fibroblasts after using GAPDH as loading 
control [(D) full blot is shown in the Supplemental Information, Full Original Blots-III]. The same blot was 
stripped and re-blotted using anti-GAPDH antibody for loading control. Immunoblot analysis of p27 in MRC-5 
cells grown under normal conditions (control) or exposed to CM derived from ATC cells, 8505c and KTC-2, 
for 24 h and 48 h (E). The figure shows a representative Western Blot of 3 independent experiments (n = 3) with 
duplicate samples for each experimental group. Quantification of relative expression of p27 protein in human 
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the activated Akt signaling induced by ATC cells-derived CM treatment to fibroblasts also contributes to higher 
cell proliferation rate in human fibroblasts.
Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases 
involved in many cellular programs, such as cell proliferation among others. Thus, we evaluated whether ATC 
cell-derived CM stimulated the activity of ERK1/2 and their possible contribution to cell proliferation observed in 
MRC-5 cells. We did not detect any changes in phosphorylated ERK1/2 under the same experimental conditions 
(Fig. S2).
Altogether, these results provide additional evidence that paracrine signaling within ATC cells-derived CM 
promoted MRC-5 proliferation through the activation of the Src kinase via, at least in part, Akt signaling and does 
not alter ERK 1/2 signaling.
MRC-5 cells activated by ATC cells-derived CM enhanced their synthetic and secretory func-
tions. Reprogramming fibroblasts into CAFs also involves changes in synthetic and secretory functions of 
those cells7,8,13. Within those paracrine alterations, activated fibroblasts are known to gain the expression of, 
among other proteins, vimentin. Consistently, Western Blot analysis revealed an up-regulation of the mesenchy-
mal marker vimentin in MRC-5 cells after treatment for 72 h with 8505c-derived CM [Fig. 4A, compare lanes 1 
(controls with 5% FBS), with lanes 2 and 3]. We obtained similar results for MRC-5 by using CM obtained from 
KTC-2 cells [Fig. 4A, compare lanes 1 (controls with 5% FBS) with lanes 4 and 5]. The quantitative data of the 
band intensities are shown in Fig. 4B.
Given the robust role of IL-6 as a pro-tumorigenic cytokine in several types of cancer, we therefore assayed 
alterations in their levels. In keeping with our previous observations (Fig. 1F–I), we observed that the treatment 
of MRC-5 cells for 48 h with CM derived from 8505c cells as well as KTC-2 cells induced a strong release in the 
secretion of IL-6 at 24 and 48 h (Fig. S3). Taken together, our data indicate that paracrine factors released from 
human ATC cells reprogram the secretory phenotype of human fibroblasts and activate them into CAFs.
The inhibition of ROS altered the metabolic reprogramming of MRC-5 cells triggered by ATC 
cells-derived CM, but no effect on the expression of IL-6 mRNA. Our data indicated that during 
co-culturing in transwell chambers with 8505c cells, the intracellular ROS levels in MRC-5 cells were significantly 
increased (Fig. 1D and E). We investigated the involvement of ROS on the activated-phenotype of human normal 
fibroblasts. We first analyzed the effect of ATC cells-derived CM on the intracellular ROS levels in MRC-5 cells. 
Consistent with the transwell system, MRC-5 cells incubated for 24 h with CM derived from KTC-2 cells show an 
increased in ROS production compared with complete media (Fig. 5, compare A and B), whereas this increase in 
ROS following the combination treatment was blocked in the presence of the ROS scavenger, N-acetyl-L-cysteine 
(NAC, 10 mM) (Fig. 5C). Similar results were obtained by stimulation with 8505c-derived CM (data not shown).
To further investigate ROS effects on the metabolic reprogramming of human normal fibroblasts, we next 
evaluated the glucose uptake in MRC-5 cells in response to ATC cells-derived CM. Consistent with our previous 
findings of increased expression of GLUT-1 in MRC-5 cells during co-culturing with ATC cells (Fig. 1L and 1M), 
glucose incorporation significantly increased in MRC-5 cells incubated for 24 h with 8505c-derived CM com-
pared with complete media [Fig. 5, compare D, E and G (quantitative analysis)]. We further evaluate this effect in 
the presence of NAC and observed a significant decrease in glucose uptake after combination treatment of ROS 
scavenger with 8505c-derived CM [Fig. 5, compare E, F and G (quantitative analysis)].
We next examined the transcription of the glycolytic enzyme, LDH-A, following NAC treatment. Similar to 
the transwell system, treatment with CM derivate from 8505c cells, significantly increased their mRNA levels 
in MRC-5 cells at 24 h (Fig. 5H). Most interestingly, the combination treatment with 10 mM NAC, inhibited 
the increase in the mRNA levels of LDH-A (Fig. 5H). Similar results were obtained by stimulation with KTC-
2-derived CM (data not shown).
As was previously mentioned, the enhanced glucose uptake and glycolysis is partly due to highly expressed 
HIF-1α. Therefore, we next explored the effect of NAC on the mRNA levels of HIF-1α. As determined by qPCR, 
we found that combination treatment of 8505c-derived CM and 10 mM NAC, significantly reduced the increase 
in the mRNA levels of HIF-1α in MRC-5 cells (Fig. 5I). In contrast, the combination treatment of 8505c-derived 
CM and 10 mM NAC did not alter the mRNA levels of IL-6 in MRC-5 cells (Fig. 5J). These data indicate that the 
ROS was increased in human fibroblasts by ATC cells-derived CM, positively modulates glucose metabolism 
fibroblasts after using GAPDH as loading control [(F); full blot is shown in the Supplemental Information, 
Full Original Blots-III]. The same blot was cut and blotted using anti-GAPDH antibody for loading control. 
Immunoblot analysis of Src in MRC-5 cells grown under normal conditions (control) or exposed to CM derived 
from ATC cells, 8505c and KTC-2, for 24 h (G). The figure shows a representative Western Blot of 4 independent 
experiments (n = 4) with duplicate samples for each experimental group. Quantification of relative expression 
of pSrc/Total Src proteins in human fibroblasts [(H); full blot is shown in the Supplemental Information, Full 
Original Blots-III]. The same blot was stripped and re-blotted using anti-Total Src antibody. Data are expressed 
as mean ± SD. Immunoblot analysis of Akt in MRC-5 cells grown under normal conditions (control) or exposed 
to CM derived from ATC cells, 8505c and KTC-2, for 24 h and 48 h (I). The figure shows a representative 
Western Blot of 3 independent experiments (n = 3) with duplicate samples for each experimental group. 
Quantification of relative expression of pAkt/Total Akt proteins in human fibroblasts [(J); full blot is shown in 
the Supplemental Information, Full Original Blots-III]. The same blot was stripped and re-blotted using anti-
Total Akt antibody. Data are expressed as mean ± SD. *p < 0.05 and **p < 0.005. ns, not significant.
8Scientific RepoRts | (2019) 9:8028 | https://doi.org/10.1038/s41598-019-44361-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
through regulation of HIF-1α. On the other hand, the increased expression of IL-6 mRNA levels induced by 
8505c-derived CM was independent of ROS.
Induction of CAF-marker protein expression in human thyroid fibroblasts during co-cultures. We 
next tested whether human thyroid fibroblasts would be similarly activated as MRC-5 cells did by ATC cells. 
Figure 6A shows the activation markers, PDGFR-β (panel a) and α-SMA (panel b) were elevated in human thyroid 
fibroblasts when cultured in the 8505c-derived CM [Fig. 6A, a and b: compare lanes 1 and 2 (controls) with lanes 3 
and 4, respectively; also see the quantitation graph, Fig. 6B]. α-SMA was also shown to be elevated in human thyroid 
fibroblasts by the transwell assays [Fig. 6C, compare lanes 1 and 2 (controls) with lanes 3 and 4; see also quantitative 
data shown in Fig. 6D].
We next further analyzed the CM derived from ATC cells could also activate the expression of vimentin, an 
EMT marker, in human thyroid fibroblasts as in MRC-5 cells. Similar to that shown for MRC-5 cells (see Fig. 4A 
and 4B), we found that vimentin was significantly elevated after treatment of human thyroid fibroblasts with 
8505c-derived CM [Fig. 6E, compare lanes 1 and 4 (controls) with lanes 2 and 3 (48 h) and lanes 5 and 6 (72 h); 
see also quantitative data shown in Fig. 6F]. The glucose transporter 1, GLUT-1, was also markedly increased in 
human thyroid fibroblasts cultured in the CM derived from 8505c cells at 72 h, as shown for MRC-5 cells [Fig. 6G, 
compare lane 4 (control) with lanes 5 and 6 (72 h); see also quantitative data shown in Fig. 6H]. The activation 
of similar markers (PDGFR-β, α-SMA, vimentin and GLUT-1) suggested that ATC cells could activate human 
thyroid fibroblasts as in MRC-5 cells.
Induction of epithelial-to-mesenchymal transition (EMT) by treatment with CM from activated 
fibroblasts to increase proliferation and invasion of follicular FTC-133 cells. Activated fibroblasts 
have been reported to affect tumor malignancy mainly through secretion of cytokines, chemokines, and growth 
factors, thereby enhancing cancer cell proliferation and invasive properties. We therefore next explored the func-
tional effects of soluble factors secreted from MRC-5 cells after activation with ATC cells-derived CM in thy-
roid carcinogenesis. To do so, we collected CM from MRC-5 cells cultured with CM of 8505c and KTC-2 cells 
for 48 h. After 48 h, we replaced media to fresh media containing 5% FBS for an additional 48 h. The collected 
supernatant [(labeled as MRC-5 CM (ATC)] was then used to treat FTC-133 cancer cells for analyses of cell pro-
liferation (Fig. 7A). The results showed that thyroid cancer cells treated with the CM from MRC-5 activated with 
8505c-derived CM increased the proliferation in a time-dependent manner (Fig. 7B). Similar results in FTC-133 
cell proliferation were obtained by using CM from MRC-5 activated with KTC-2-derived CM (Fig. 7B).
To investigate whether CM from MRC-5 activated by ATC-derived CM affected invasion of cells, we carried 
out cell invasion assays. Importantly, cell invasiveness of FTC-133 cells was significantly increased after treatment 
with CM of fibroblasts induced for 48 h with ATC cells-derived CM, compared to control (Fig. 7C).
We next focused on the analysis of regulators affecting cell motility and migration. We examined the markers 
of EMT after the treatment of FTC-133 cells with CM from MRC-5 activated by ATC-derived CM. As shown in 
Fig. 7D, treatment with MRC-5 CM led to an increase of vimentin protein abundance as compared with FTC-
133 control cells (see also the quantification in Fig. 7E). We also determined the levels of other EMT marker, 
E-cadherin, because its repressed expression is a hallmark of EMT. Indeed, E-cadherin was decreased after treat-
ment with CM from MRC-5 activated by ATC-derived CM compared with controls FTC-133 cells (Fig. 7D, see 
also the quantification in Fig. 7E). Taken together, these data indicate that CM from MRC-5 activated by ATC 
cells-derived CM increased tumor cell proliferation, invasion and activation of EMT.
Figure 4. MRC-5 cells activated by ATC cells-derived CM enhanced their synthetic and secretory functions. 
Immunoblot analysis of vimentin in MRC-5 cells grown under normal conditions (control) or exposed to CM 
derived from ATC cells, 8505c and KTC-2, for 72 h (A). The figure shows a representative Western Blot of 3 
independent experiments (n = 3) with duplicate samples for each experimental group. Quantification of relative 
expression of vimentin protein in human fibroblasts after using GAPDH as loading control [(B) full blot is 
shown in the Supplemental Information, Full Original Blots-IV]. The same blot was stripped and re-blotted 
using anti-GAPDH antibody for loading control. Data are expressed as mean ± SD. *p < 0.05 and **p < 0.01.
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Discussion
The role of neoplastic epithelial cells in tumorigenesis, including thyroid cancer, has been extensively investi-
gated for several decades. However, less attention has been paid to the study of the surrounding TME in these 
events. It has been demonstrated that the TME, which is composed of many stromal cells (particularly fibro-
blasts), plays a key role in tumor progression7,8,14. Consequently, in the present study, we analyzed the interplay 
between fibroblasts and ATC cells and how these interactions can promote TC. We demonstrated the function of 
tumor-secreted factors from two well-characterized ATC cell lines on the reprogrammed-phenotype of human 
normal fibroblasts, and found that the treated quiescent fibroblasts with ATC cells-derived CM became more pro-
liferative, acquired an active secretome and were more active metabolically, with all these changes being related to 
a phenotype of activated-fibroblast or CAF7,13. The reprogramming of quiescent fibroblasts into CAFs was further 
confirmed by the up-regulation of PDGFR-β and α-SMA, both acknowledged markers of CAFs. These effects 
were mediated, at least in part, through the activation of Src and its downstream target Akt, in fibroblasts. Finally, 
the secretome from activated-fibroblasts led to significant changes in the proliferation and invasion of follicular 
thyroid cancer cells (Fig. 8). Taken together, our findings implicate secreted factors from activated fibroblasts by 
ATC cells-derived CM, as being a key event in TC progression.
Previous studies have shown that tumor cells secrete multiple factors, including growth factors and cytokines, 
among others, which drive the reprogramming of fibroblasts into CAFs8,12. By focusing on the anaplastic thyroid 
tumor cell secretome effects exerted in the immediate proximity of stromal cells, we demonstrated that soluble 
factors secreted by ATC cells induced fibroblast activation in both transwell co-cultures as well as with ATC 
cells-derived CM. In fact, the release of ROS by tumor cells is known to promote the activation of fibroblasts 
Figure 5. ATC cells-derived CM increased glucose uptake through ROS generation, in MRC-5 cells. Total 
intracellular levels of ROS in MRC-5 by flow cytometry. Representative histograms are shown of 2 independent 
experiments (n = 2) with triplicate samples for each experimental group. (A–C) Basal ROS production in 
MRC-5 cells grown under normal conditions (A) and incubated with KTC-2-derived CM for 24 h in the 
absence (B) or presence of the ROS scavenger NAC (10 mM) (C). Glucose uptake using the fluorescent 
glucose analog, 2-NBDG, followed by flow cytometry. Representative histograms (D–F) of 2 independent 
experiments (n = 2) with triplicate samples for each experimental group, and quantification (G) are shown. 
Data are expressed as mean ± SD. Basal glucose uptake in MRC-5 cells grown under normal conditions (D) and 
incubated with 8505c-derived CM for 24 h in the absence (E) or presence of the ROS scavenger NAC (10 mM) 
(F). Expression levels of LDH-A (H), HIF-1A (I) and IL-6 (J). mRNA levels by RT-qPCR in MRC-5 grown 
under normal conditions and incubated with 8505c-derived CM for 24 h in the absence or presence of NAC 
(10 mM). Data are expressed as mean ± SD of 3 independent experiments (n = 3) with triplicate samples for 
each experimental group. *p < 0.05, **p < 0.005 and ****p < 0.0001. ns, not significant.
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Figure 6. Co-cultures of ATC cells with fibroblasts induce the protein expression of CAF-markers in human 
thyroid fibroblasts. Effects of CM from 8505c cells on CAFs markers in human thyroid fibroblasts (A–D). 
(A) Immunoblot analysis of PDGFR-β (a) and α-SMA (b) in human thyroid fibroblasts, grown under normal 
conditions (lanes 1 and 2) or exposed to CM derived from 8505c cells for 48 h (lanes 3 and 4). The figure shows a 
representative Western Blot of 2 independent experiments (n = 2) with duplicate samples for each experimental 
group. (B) Quantification of relative expression of PDGFR-β and α-SMA proteins in human thyroid fibroblasts 
after using GAPDH as loading control. [Full blots are shown in the Supplemental Information, Full Original 
Blots-VI]. Data are expressed as mean ± SD. (C) Immunoblot analysis in human thyroid fibroblast after 48 h of 
co-cultures with ATC cells. Immunoblot analysis of α-SMA (a) in mono-cultures of human thyroid fibroblast 
(lanes 1 and 2) or after co-cultures with 8505c cells (lanes 3 and 4) in 12-well transwell system, for 48 h. The 
figure shows a representative Western Blot of 2 independent experiments (n = 2) with duplicate samples for each 
experimental group. (D) Quantification of relative expression of α-SMA protein in human thyroid fibroblasts 
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in many tumor types, and several studies have highlighted the role of ROS in the conversion of quiescent fibro-
blasts into activated-fibroblasts, through an increase of CAF markers. In contrast, antioxidants have been found 
to inhibit these activated-fibroblast features8,16. In agreement, we found that ROS are abundantly produced by 
mono-cultures of 8505c cells, suggesting that ROS could be one of the tumor signals involved in the phenotypic 
reprogramming of fibroblasts, with a co-culture with 8505c cells as well as incubation with ATC cells-derived 
CM inducing the generation of high levels of ROS in MRC-5 cells (Figs 1D and E and 5B). Here we also demon-
strated antioxidant NAC attenuate glucose uptake in human fibroblasts, after having been treated with ATC 
cells-derived CM (Fig. 5F and G). Importantly, this effect is partially mediated by inhibition of HIF-1α (Fig. 5I), 
and a reduction in the HIF-1α mRNA expression level may lead to a decrease in the transcription of the glucose 
metabolism-related genes LDH-A (Fig. 5H) and GLUT-1. Consequently, given that HIF-1α undergoes posttran-
scriptional regulation27, HIF-1α protein modifications would be expected to occur. These results suggest that 
increases in ROS production is partially involved in the metabolic reprogramming mediated by ATC cells-derived 
CM and support our proposal that ROS could be one of the positive mediators involved in fibroblast activation.
In addition to ROS, cytokines have been shown to be released by cancer cells and affect the differentiation of 
fibroblasts. In particular, IL-6 is also known to elicit a fibroblast activated phenotype, and consistent with these 
results, increased IL-6 basal levels secreted by KTC-2 cells were found. Thus, in our study, fibroblast activation 
and differentiation may be in part mediated by the inflammatory cytokine IL-6, secreted from ATC cells, as well 
as by ROS. However, further studies are needed to investigate their participation. Moreover, we cannot rule out 
other paracrine mediators derived from ATC cells being responsible for the phenotypic and functional changes 
of human fibroblasts. Taken together, our results suggest a fibroblast differentiation to CAFs induced by ATC 
cells-derived CM.
Reprogramming fibroblasts into CAFs involves the activation of multiple signaling pathways, with previous 
studies having implicated the Src family kinase pathway as being essential for myofibroblast differentiation25. Our 
findings suggest that the Src pathway is involved in MRC-5 cells proliferation, differentiation and activation after 
ATC cells-derived CM treatment. The Src tyrosine kinases are redox regulated proteins and we have observed that 
large amounts of oxidants are produced by anaplastic thyroid tumor cells. We speculate that the activation of Src 
in MRC-5 cells during co-cultures may be mediated by ATC cells-derived ROS, as has been previously described 
by others, resulting later in the activation of the Akt pathway. Based on these data, we hypothesize that Src kinase 
regulates fibroblast activation, at least in part, through an Akt-dependent pathway. Further studies are needed to 
explore other ATC cell-derived factors, as well as the pathways involved in phenotypic reprogramming of human 
fibroblasts.
Once transformed into CAFs, activated fibroblasts reprogram their metabolic and their secretory phenotype 
to enhance tumor progression8,17, thus provoking the question of whether these metabolic shifts, as well as factors 
secreted by activated fibroblasts with ATC cells-derived factors, could regulate TC proliferation and invasion. 
In this regard, we observed that treatment with CM of fibroblasts activated by ATC cells-derived CM promoted 
cell proliferation and invasion of the follicular thyroid cancer cell line, FTC-133 (Fig. 7), with it being clear that 
these effects were mediated by soluble factors produced by activated fibroblasts. Our results demonstrated that 
activated fibroblasts produce and secrete very high levels of IL-6, which could represent a key candidate factor for 
increasing FTC-133 cell proliferation and invasion. However, we speculate that IL-6 is not the only factor involved 
in these events.
The cellular components of the thyroid tumor stroma include, among others, endothelial cells and 
immune cells, in addition to activated fibroblasts. In the current study, we focused our analysis on activated 
fibroblast-derived signals on thyroid tumor progression. Nevertheless, we cannot rule out the possibility that 
secretome from other cell components of the TME could also play a major role in TC progression, thereby con-
tributing to thyroid carcinogenesis. Further studies exploring how these components may work together to pro-
mote anaplastic thyroid carcinogenesis could help to address this issue in the future.
The recruitment of fibroblasts in mouse models of papillary thyroid cancer was previously reported28,29. 
However, there are still many unanswered questions, such as which oncogenic signals are responsible for the 
recruitment of fibroblasts into thyroid TME and how they act. Further in vivo studies would be helpful to eluci-
date this key event.
In conclusion, our study provides evidence that human ATC cells-derived soluble factors contribute to the 
phenotypic, secretory and metabolic reprogramming of human fibroblasts, which favor TC development and 
after using GAPDH as loading control (Full blots are shown in the Supplemental Information, Full Original 
Blots-VI). Data are expressed as mean ± SD. (E) Immunoblot analysis of vimentin in human thyroid fibroblasts 
grown under normal conditions (lanes 1 and 4) or exposed to CM derived from 8505c for 48 h (lanes 2 and 3) 
and 72 h (lanes 5 and 6). The figure shows a representative Western Blot of 2 independent experiments (n = 2) 
with duplicate samples for each experimental group. (F) Quantification of relative expression of vimentin 
protein in human thyroid fibroblasts after using GAPDH as loading control. The same blot was stripped and re-
blotted using anti-GAPDH antibody for loading control (Full blots are shown in the Supplemental Information, 
Full Original Blots-VI). Data are expressed as mean ± SD. (G) Immunoblot analysis of GLUT-1 in human 
thyroid fibroblasts grown under normal conditions (lanes 1 and 4) or exposed to CM derived from 8505c for 
48 h (lanes 2 and 3) and 72 h (lanes 5 and 6). The figure shows a representative Western Blot of 2 independent 
experiments (n = 2) with duplicate samples for each experimental group. (H) Quantification of relative 
expression of GLUT-1 protein in human thyroid fibroblasts after using GAPDH as loading control. The same 
blot was stripped and re-blotted using anti-GAPDH antibody for loading control. [Full blots are shown in the 
Supplemental Information, Full Original Blots-VI]. Data are expressed as mean ± SD.
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progression. Taken together, our findings contribute to a better understanding of the molecular basis of interac-
tions between anaplastic thyroid tumor cells and stromal cells. Furthermore, these data may lead to the identifica-
tion and targeting of thyroid tumor-supportive mechanisms. However, whether or not this phenomenon occurs 
in vivo still remains to be clarified.
Materials and Methods
Cell cultures. Human fibroblasts, MRC-5 cells, were obtained from ATCC (ATCC CCL-171) and used at 
passage number ranged from 23 to 29. Human thyroid fibroblasts were purchased from ScienCell Research 
Laboratories (#3730).
Human ATC cells, 8505c and KTC-2 (passage number ranged from 10 to 15), were authenticated by short tan-
dem repeat (STR) profiling analysis by the Science Cordoba Agency (CEPROCOR, Córdoba, Argentina). Briefly, 
samples were amplified by PowerPlex Fusion kit (Promega) and after capillary electrophoresis (GA 3130-Applied 
Biosystems), the data were analyzed with Gene Mapper Software v3.2 (Applied Biosystems). All cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS) 
(Hyclone), 100 units/mL penicillin, and 100 μg/mL streptomycin (Gibco). Human follicular thyroid cancer cells, 
FTC-133, were cultured in DMEM/ Ham’s F12 (1:1) medium (Gibco) supplemented with 10% FBS (Hyclone), 
Figure 7. Treatment with CM from activated fibroblasts increased proliferation and invasion of FTC-133 
cells. (A) Schematic representation of CM preparation from MRC-5 cells and treatment of FTC-133 cells. 
Cell proliferation (B) and in vitro invasion assays (C) were performed in FTC-133 cells incubated with CM 
derived from activated MRC-5 cells, as described in the Materials and Methods section. Data are expressed as 
mean ± SD of 3 independent experiments (n = 3) with quadruplicate samples for each experimental group. 
(D) Immunoblot analysis of vimentin, E-cadherin and GAPDH as a loading control after treatment with 
CM derived from activated MRC-5 cells. The figure shows representative Western Blots of 3 independent 
experiments (n = 3) with duplicate samples for each experimental group. (E) Quantification of relative 
expression of proteins associated with EMT in FTC-133 after using GAPDH as loading control (Full blots are 
shown in the Supplemental Information, Full Original Blots-VII). Data are expressed as mean ± SD.*p < 0.05 
and **p < 0.01.
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100 units/mL penicillin, and 100 μg/mL streptomycin (Gibco), as previously described30. FTC-133 cells retained 
differentiated thyrocyte function and thyrocyte responsiveness to thyrotropin and local active growth factors.
Co-cultures in transwell system. For non-contact co-cultures, human MRC-5 cells were seeded (3 × 105 
or 1 × 105 cells) in the lower wells of a transwell system (6-well or 12-well types respectively) and ATC cells were 
cultured in the upper chambers (cell culture inserts polyester membrane with 0.4 μm pores to allow the diffusion 
of the soluble factors only; Corning) (Fig. 1A). After 24 h and 48 h of incubation, the culture medium and cells 
were harvested and intracellular levels of ROS, secretion and expression of interleukin-6 (IL-6), expression of 
the hypoxia inducible transcription factor-1α (HIF-1α), glucose transporter 1 (GLUT-1), lactate dehydrogenase 
A (LDH-A), platelet-derived growth factor receptor–β (PDGFR-β) and α-smooth muscle actin (α-SMA) were 
evaluated by flow cytometry, quantitative real time reverse transcription polymerase chain reaction (RT-qPCR), 
enzyme-linked immunosorbent assay (ELISA) and Western Blotting respectively. Mono-cultures of MRC-5, 
8505c and KTC-2 cells were processed as controls.
Determination of intracellular levels of ROS. Cells were incubated with 10 μM 2′, 7′-dichlorodihydro 
fluorescein diacetate, (H2DCFDA, Molecular Probes) in phosphate buffered saline (PBS) (Gibco). After 30 min 
at 37 °C, cells were washed and re-suspended in saline solution with 2% FBS. Detection of ROS levels was carried 
out through flow cytometric analyses using a FACS Canto II flow cytometer (BD Biosciences) with FlowJo soft-
ware (version 7.6.2).
Determination of IL-6 by ELISA. Culture supernatants were harvested, clarified by centrifugation, and 
frozen for the subsequent determination of IL-6 concentration by ELISA according to the manufacturer’s instruc-
tions (#430501, eBiolegend).
Quantification of platelet-derived growth factor (PDGF) by ELISA. Cell culture supernatant was 
collected 48 h and centrifuged to remove particulates before being stored at −80 °C. Culture medium from nor-
mal thyroid served as a control. Concentrations of PDGF in CM from each cell lines were measured using ELISA 
kits (abcam, ab100624 for sub-type PDGF-BB) according to the manufacturer’s instructions. And the absorbance 
was read at 450 nm with SpectraMax 250 micro titer plate reader. For wavelength correction, subtract readings at 
570 nm from the readings at 450 nm.
RNA Isolation and quantitative real-time RT-PCR. Total RNA purification, cDNA synthesis, and quan-
titative PCR (qPCR) were performed as previously described31,32. The specific primer sequences were as follows: 
hGLUT-1 forward, 5′-TCACTGTGCTCCTGGTTCTG-3′ and reverse, 5′-CCTGTGCTCCTGAGAGATCC-3′; 
hHIF-1A forward, 5′-AGCCAGATCTCGGCGAAGT-3′ and reverse, 5′-CAGAGGCCTTATCAAGATGCG-3′; 
hIL-6 forward, 5′-TCAATGAGGAGACTTGCCTG-3′ and reverse, 5′-TCATCTGCACAGCTCTGGCT-3′; 
hLDH-A forward, 5′-CAGGTGGTTGAGAGGGTCTTT-3′ and reverse, 5′-CTTCAAACGGGCCTCTTCCT-3′. 
hGAPDH forward, 5′-TTG TTG CCA TCA ATG ACC CCT T-3′ and reverse, 5′-CAG TGG ACT CCA CGA 
CGT ACT CAG-3′.
Western Blot analysis. Whole-cell lysates was prepared as previously described30. The protein samples 
(20–30 µg) were analyzed by Western blot as described previously32. Antibodies used according to the manufac-
turers’ manuals include GLUT-1 (#12939) from Cell Signaling and used at a 1:600 dilution. PDGFR-β (sc-374573) 
Figure 8. Proposed model describing the paracrine loop existing between anaplastic thyroid tumor cells and 
stromal fibroblasts in TC. Soluble signals derived from ATC cells promotes the up-regulation of pSrc and pAkt 
in human fibroblasts, leading to increased cell proliferation, secretory functions and metabolic reprogramming 
of fibroblasts, consistent with the induction of CAF phenotype. Moreover, CM from activated fibroblasts 
promoted thyroid cell proliferation and invasion, thereby increasing TC progression.
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and α-SMA (sc-53015) antibodies were purchased from Santa Cruz Biotechnology and used at a 1:200 dilution. 
Anti-p21 (#2947), anti-phosphorylated Akt (Ser473, #9271), Akt (#9272), phosphorylated Src (tyr416,#2101), 
total Src (#2110), vimentin (#5741), anti pErk1/2 (#9102) and GAPDH (#2118), all from Cell Signaling and used 
at a 1:1000 dilution. The antibody to p27 (#ab137736) (1:2000 dilution) was purchased from Abcam. Band inten-
sities were quantified by using NIH IMAGE software (ImageJ 1.50i; NIH).
Conditioned media (CM) harvesting. CM preparation from tumor cell lines: ATC cells (8505c and KTC-
2) were seeded (1 × 106 cells) on 100 mm tissue culture plates in DMEM 10% FBS. After 48 h incubation, the 
media were replaced with media with 5% FBS. After additional 48 h, CM were collected and clarified by centrifu-
gation (2000 rpm for 10 min) and labeled as 8505c CM FBS 5% or KTC-2 CM FBS 5%, respectively. CM produced 
was used for the treatment (24h–72h) of MRC-5 cells (Fig. 2A).
CM from MRC-5 cells: To explore the effects of secreted factors present in the CM of MRC-5 cells after induc-
tion with ATC cells-derived CM on thyroid carcinogenesis, we generated CM by culturing fibroblasts (1.5 × 106 
cells on 100 mm plates) with ATC cells-derived CM for 48 h as described above. The media was replaced to fresh 
media containing 5% FBS. After 48 h, the supernatant was harvested [labeled as MRC-5 CM (ATC)], centrifuged 
and used for proliferation, migration and Western Blot assays of thyroid FTC-133 cells (Fig. 7A).
MTT assay. The assay was optimized for the MRC-5 cells. Briefly, at the end of the incubation time, MRC-5 
cells were incubated for at 37 °C for 4 h with 0.5 mg/ml of MTT, dissolved in serum free medium. Washing with 
PBS was followed by the addition of dimethyl sulfoxide (DMSO), gentle shaking for 10 min so that complete dis-
solution was achieved. Aliquots of the resulting solutions were transferred in 96-well plates and absorbance was 
measured at 540 nm using a microplate reader (Bio-Rad).
Glucose uptake assays. MRC-5 cells were incubated for 2 h in 100 μl glucose-free media 1% FBS. Then, 
culture medium was removed from each well and replaced with 100 μl of culture medium in the absence or pres-
ence of the fluorescent 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) (10 ug/ml) 
(Invitrogen). Cells were cultured for 2 h before measuring fluorescence by flow cytometry (BD Biosciences).
In vitro cell proliferation assay. Cell proliferation assay was performed as previously described with minor 
modifications30. Briefly, 5 × 104 FTC-133 cells were seeded in six-well plates in medium supplemented with 1% 
FBS. Next day (day 0) cells were cultured in MRC-5 CM (8505c) or MRC-5 CM (KTC-2), replacing the MRC-5 
CM (ATC) every 48 h (Fig. 7A). Nonattached cells were removed by gently washing twice with PBS. After trypsin 
treatment and resuspension, the number of attached cells was counted every 24 h from day 2–5 by using an auto-
mated cell counter (ThermoFisher Scientific).
Invasion assay. Invasion assay was performed as described previously33 in 8-μm−pore transwells (Corning) 
in quadruplicate. Transwell filters were layered with 200 μL of Matrigel (BD Biosciences) diluted 1:10 in PBS. 
After rinsing with PBS, cells were plated in the upper chambers (5 × 104 cells/24 well plates) and the MRC-5 CM 
(8505c) or MRC-5 CM (KTC-2) (Fig. 7A) in the lower wells (500 μL). 48 h later, cells migrating to the bottom of 
the filter were evaluated after removal of material from the upper side of the filter, with 0.1% crystal violet staining 
and measurement of solubilized dye at 590 nm.
Statistical analysis. Analysis of intergroup differences was conducted by one-way analysis of variance 
(ANOVA), followed by the Turkey’s test and for the analysis of differences between two groups statistical analyses 
were performed using the Student’s t-test, with the use of GraphPad Prism 6.01 (GraphPad Software). Values of 
p < 0.05 were considered to be statistically significant.
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